These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 11752111

  • 1. Relationship between rate and extent of G protein activation: comparison between full and partial opioid agonists.
    Traynor JR, Clark MJ, Remmers AE.
    J Pharmacol Exp Ther; 2002 Jan; 300(1):157-61. PubMed ID: 11752111
    [Abstract] [Full Text] [Related]

  • 2. G protein activation by endomorphins in the mouse periaqueductal gray matter.
    Narita M, Mizoguchi H, Narita M, Dun NJ, Hwang BH, Endoh T, Suzuki T, Nagase H, Suzuki T, Tseng LF.
    J Biomed Sci; 2000 Jan; 7(3):221-5. PubMed ID: 10810240
    [Abstract] [Full Text] [Related]

  • 3. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
    Ko MC, Lee H, Harrison C, Clark MJ, Song HF, Naughton NN, Woods JH, Traynor JR.
    J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
    [Abstract] [Full Text] [Related]

  • 4. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
    Alt A, McFadyen IJ, Fan CD, Woods JH, Traynor JR.
    J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532
    [Abstract] [Full Text] [Related]

  • 5. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain.
    Sim LJ, Childers SR.
    J Comp Neurol; 1997 Oct 06; 386(4):562-72. PubMed ID: 9378852
    [Abstract] [Full Text] [Related]

  • 6. Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouse.
    Mizoguchi H, Wu HE, Narita M, Hall FS, Sora I, Uhl GR, Nagase H, Tseng LF.
    Neuroscience; 2002 Oct 06; 115(3):715-21. PubMed ID: 12435410
    [Abstract] [Full Text] [Related]

  • 7. Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes.
    Breivogel CS, Selley DE, Childers SR.
    J Neurochem; 1997 Apr 06; 68(4):1462-72. PubMed ID: 9084416
    [Abstract] [Full Text] [Related]

  • 8. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M, Mizoguchi H, Narita M, Sora I, Uhl GR, Tseng LF.
    Br J Pharmacol; 1999 Jan 06; 126(2):451-6. PubMed ID: 10077238
    [Abstract] [Full Text] [Related]

  • 9. [(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord.
    Madia PA, Navani DM, Yoburn BC.
    Pharmacol Biochem Behav; 2012 Mar 06; 101(1):155-65. PubMed ID: 22108651
    [Abstract] [Full Text] [Related]

  • 10. Activation of G-proteins in the mouse pons/medulla by beta-endorphin is mediated by the stimulation of mu- and putative epsilon-receptors.
    Mizoguchi H, Narita M, Nagase H, Tseng LF.
    Life Sci; 2000 Oct 20; 67(22):2733-43. PubMed ID: 11105989
    [Abstract] [Full Text] [Related]

  • 11. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
    Traynor JR, Nahorski SR.
    Mol Pharmacol; 1995 Apr 20; 47(4):848-54. PubMed ID: 7723747
    [Abstract] [Full Text] [Related]

  • 12. Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.
    Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F.
    J Pharmacol Exp Ther; 1996 Sep 20; 278(3):1121-7. PubMed ID: 8819494
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relationship of mu opioid receptor binding to activation of G-proteins in specific rat brain regions.
    Maher CE, Selley DE, Childers SR.
    Biochem Pharmacol; 2000 Jun 01; 59(11):1395-401. PubMed ID: 10751548
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
    Liu JG, Prather PL.
    Mol Pharmacol; 2001 Jul 01; 60(1):53-62. PubMed ID: 11408600
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors.
    Liu JG, Prather PL.
    J Pharmacol Exp Ther; 2002 Sep 01; 302(3):1070-9. PubMed ID: 12183665
    [Abstract] [Full Text] [Related]

  • 20. mu-opioid receptor and alpha2-adrenoceptor agonist stimulation of [35S]GTPgammaS binding to G-proteins in postmortem brains of opioid addicts.
    Meana JJ, González-Maeso J, García-Sevilla JA, Guimón J.
    Mol Psychiatry; 2000 May 01; 5(3):308-15. PubMed ID: 10889534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.